{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:11:15Z","timestamp":1787616675238,"version":"build-2736575974"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The membrane-bound protease Eep is an important virulence factor in pathogenic enterococci. The protein is involved in stress response via the RIP pathway which is crucial for pathogenic enterococci to evade host immune attacks during infection. Eep serves also as a receptor for the bacteriocins enterocin K1 and enterocin EJ97. The bacteriocins kill <jats:italic>Enterococcus faecium<\/jats:italic> and <jats:italic>E. faecalis<\/jats:italic>, respectively, and their antibiotic resistant derivatives including vancomycin resistant enterococci (VRE). This functional duality of Eep makes these two enterocins very promising as options in the prospective treatment of enterococcal infections because wildtype enterococcal cells (with an intact Eep) are sensitive to the bacteriocins while bacteriocin-resistant-mutants (without a functional Eep) become less virulent. As a first step to explore their therapeutic potential in the treatment of systemic enterococcal infections, we investigated the compatibility of the bacteriocins with human blood, and the phenotypic changes of <jats:italic>eep<\/jats:italic>-mutants toward different stress conditions. We found that the bacteriocins were compatible with blood, as they did not cause haemolysis and that the bacteriocins retained most of their antibacterial effect when incubated in blood. The bacteriocins were autoclavable which is a crucial criterium for the development of parenteral administration. <jats:italic>Eep<\/jats:italic>-mutants, which became resistant to the bacteriocin were, as expected, less capable to withstand stress conditions such as exposure to lysozyme and desiccation. Further, their ability to chain, a trait implicated in niche adaptation as well as being necessary for genetic transfer via conjugation, was also severely affected. Together, these results indicate that the bacteriocins are promising for treatment of VRE infection.<\/jats:p>","DOI":"10.3389\/fmicb.2021.649339","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:21:57Z","timestamp":1613740917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Exploring the Therapeutic Potenital of the Leaderless Enterocins K1 and EJ97 in the Treatment of Vancomycin-Resistant Enterococcal Infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Ingvild","family":"Reinseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne H.","family":"T\u00f8nnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzung B.","family":"Diep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1128\/jb.187.3.1022-1035.2005","article-title":"The Enterococcus faecalis sigV protein is an extracytoplasmic function sigma factor contributing to survival following heat, acid, and ethanol treatments.","volume":"187","author":"Benachour","year":"2005","journal-title":"J. Bacteriol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178943","article-title":"Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.","volume":"12","author":"Bottger","year":"2017","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-7-r110","article-title":"Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF.","volume":"9","author":"Bourgogne","year":"2008","journal-title":"Genome Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1128\/jb.00183-11","article-title":"Complete genome sequence of the commensal Enterococcus faecalis 62, isolated from a healthy Norwegian infant.","volume":"193","author":"Brede","year":"2011","journal-title":"J. Bacteriol."},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-019-0466-x","article-title":"Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey.","volume":"8","author":"Buetti","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"B6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant enterococci.","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.foodchem.2017.11.116","article-title":"Preparation of extra-small nisin nanoparticles for enhanced antibacterial activity after autoclave treatment.","volume":"245","author":"Chang","year":"2018","journal-title":"Food Chem."},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1038\/srep22843","article-title":"A web server and mobile app for computing hemolytic potency of peptides.","volume":"6","author":"Chaudhary","year":"2016","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1590\/s0074-02762013000500009","article-title":"Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin.","volume":"108","author":"Comerlato","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins - a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat.Rev. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ijmm.2007.02.008","article-title":"Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1.","volume":"297","author":"Domann","year":"2007","journal-title":"Int. J. Med. Microbiol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.celrep.2018.11.007","article-title":"Antibiotic-induced cell chaining triggers pneumococcal competence by reshaping quorum sensing to autocrine-like signaling.","volume":"25","author":"Domenech","year":"2018","journal-title":"Cell Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molimm.2004.12.004","article-title":"Innate immune defence in the human gastrointestinal tract.","volume":"42","author":"Dommett","year":"2005","journal-title":"Mol. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1086\/422002","article-title":"The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens.","volume":"39","author":"Donskey","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/iai.05964-11","article-title":"Use of recombinase-based in vivo expression technology to characterize Enterococcus faecalis gene expression during infection identifies in vivo-expressed antisense RNAs and implicates the protease Eep in pathogenesis.","volume":"80","author":"Frank","year":"2012","journal-title":"Infect. Immun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1128\/iai.01210-12","article-title":"AhrC and Eep are biofilm infection-associated virulence factors in Enterococcus faecalis.","volume":"81","author":"Frank","year":"2013","journal-title":"Infect. Immun."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130187","article-title":"Evaluation of the Enterococcus faecalis biofilm-associated virulence factors AhrC and Eep in rat foreign body osteomyelitis and in vitro biofilm-associated antimicrobial resistance.","volume":"10","author":"Frank","year":"2015","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s002030050678","article-title":"Isolation and characterization of enterocin EJ97, a bacteriocin produced by Enterococcus faecalis EJ97.","volume":"171","author":"G\u00e1lvez","year":"1998","journal-title":"Arch. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215426","article-title":"Blood compatibility-an important but often forgotten aspect of the characterization of antimicrobial peptides for clinical application.","volume":"20","author":"Harm","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1128\/jcm.42.12.5895-5898.2004","article-title":"Vancomycin resistance, esp, and strain relatedness: a 1-year study of Enterococcal bacteremia.","volume":"42","author":"Harrington","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/tid.12612","article-title":"Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.","volume":"18","author":"Hefazi","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1128\/aac.36.6.1272","article-title":"Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.","volume":"36","author":"Hellinger","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/fmic.2000.0382","article-title":"Enterococcus faecium P21: a strain occurring naturally in dry-fermented sausages producing the class II bacteriocins enterocin A and enterocin B.","volume":"18","author":"Herranz","year":"2001","journal-title":"Food Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1128\/jb.173.12.3879-3887.1991","article-title":"Lactococcin a, a new bacteriocin from Lactococcus lactis subsp. cremoris: isolation and characterization of the protein and its gene.","volume":"173","author":"Holo","year":"1991","journal-title":"J. Bacteriol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1128\/aac.35.8.1626","article-title":"Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis.","volume":"35","author":"Huycke","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00253-004-1576-8","article-title":"Isolation and partial characterization of bacteriocins from Pediococcus species.","volume":"65","author":"Jamuna","year":"2004","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3892\/etm.2016.3545","article-title":"Antibiotic susceptibility, antibacterial activity and characterisation of Enterococcus faecium strains isolated from breast milk.","volume":"12","author":"Kivanc","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"B28","article-title":"Enterococcal infection-treatment and antibiotic resistance","author":"Kristich","year":"2014","journal-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00054","article-title":"A method for predicting hemolytic potency of chemically modified peptides from its structure.","volume":"11","author":"Kumar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1128\/jb.00259-12","article-title":"Comparative analysis of the first complete Enterococcus faecium genome.","volume":"194","author":"Lam","year":"2012","journal-title":"J. Bacteriol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009658","article-title":"The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis.","volume":"5","author":"Le Jeune","year":"2010","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.idc.2009.06.008","article-title":"Pharmacokinetics and pharmacodynamics of antibacterial agents.","volume":"23","author":"Levison","year":"2009","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1348-0421.1992.tb02070.x","article-title":"Proposal of a new scheme for the serological typing of Enterococcus faecalis strains.","volume":"36","author":"Maekawa","year":"1992","journal-title":"Microbiol. Immunol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2019.03.008","article-title":"Intestinal bile acids induce a morphotype switch in vancomycin-resistant enterococcus that facilitates intestinal colonization.","volume":"25","author":"McKenney","year":"2019","journal-title":"Cell Host Micrpbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1172\/jci111042","article-title":"Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.","volume":"72","author":"Murray","year":"1983","journal-title":"J. Clin. Invest."},{"key":"B36","article-title":"Enterococcal bacteriocins and antimicrobial proteins that contribute to niche control","author":"Nes","year":"2014","journal-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection"},{"key":"B37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-4939-6737-7_31","article-title":"Hemolytic activity of antimicrobial peptides.","volume":"1548","author":"Oddo","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/idr.s54125","article-title":"Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.","volume":"8","author":"O\u2019Driscoll","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00774","article-title":"The leaderless bacteriocin enterocin K1 is highly potent against Enterococcus faecium: a study on structure, target spectrum and receptor.","volume":"8","author":"Ovchinnikov","year":"2017","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"23838","DOI":"10.1074\/jbc.m114.579698","article-title":"Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB.","volume":"289","author":"Ovchinnikov","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1208\/s12249-016-0493-3","article-title":"Production of isotonic, sterile, and kinetically stable lipid-core nanocapsules for injectable administration.","volume":"18","author":"Paese","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1128\/jb.00153-10","article-title":"High-quality draft genome sequences of 28 Enterococcus sp. isolates.","volume":"192","author":"Palmer","year":"2010","journal-title":"J. Bacteriol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1060028014556879","article-title":"Vancomycin-resistant enterococcal bacteremia pharmacotherapy.","volume":"49","author":"Patel","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar6115","article-title":"Increasing tolerance of hospital Enterococcus faecium to handwash alcohols.","volume":"10","author":"Pidot","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis.","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.syapm.2012.05.004","article-title":"Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates.","volume":"35","author":"Rathnayake","year":"2012","journal-title":"Syst. Appl. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s12602-019-09618-6","article-title":"The increasing issue of vancomycin-resistant enterococci and the bacteriocin solution.","volume":"12","author":"Reinseth","year":"2020","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B48","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3109\/10428194.2013.842983","article-title":"Vancomycin-resistant enterococci infection: not just for the transplanted.","volume":"55","author":"Rosko","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1128\/aac.33.9.1588","article-title":"In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.","volume":"33","author":"Sahm","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8050639","article-title":"Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria.","volume":"8","author":"Simons","year":"2020","journal-title":"Microorganisms"},{"key":"B51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jmr.2288","article-title":"Short cationic antimicrobial peptides bind to human alpha-1 acid glycoprotein with no implications for the in vitro bioactivity.","volume":"26","author":"Sivertsen","year":"2013","journal-title":"J. Mol. Recognit."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-14-4","article-title":"Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin.","volume":"14","author":"Sivertsen","year":"2014","journal-title":"BMC Struct. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1021\/jm0703542","article-title":"Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect.","volume":"50","author":"Svenson","year":"2007","journal-title":"J. Med. Chem."},{"key":"B54","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1101\/gr.096651.109","article-title":"The NIH human microbiome project.","volume":"19","author":"The Nih Hmp Working Group, Peterson","year":"2009","journal-title":"Genome Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1128\/jb.00859-13","article-title":"A Zn-dependent metallopeptidase is responsible for sensitivity to LsbB, a class II leaderless bacteriocin of Lactococcus lactis subsp. lactis BGMN1-5.","volume":"195","author":"Uzelac","year":"2013","journal-title":"J. Bacteriol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1128\/jb.00291-13","article-title":"Eep confers lysozyme resistance to Enterococcus faecalis via the activation of the extracytoplasmic function sigma factor SigV.","volume":"195","author":"Varahan","year":"2013","journal-title":"J. Bacteriol."},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1038\/srep37907","article-title":"Limitations of MIC as sole metric of pharmacodynamic response across the range of antimicrobial susceptibilities within a single bacterial species.","volume":"6","author":"Wen","year":"2016","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4155\/fmc-2016-0188","article-title":"HemoPred: a web server for predicting the hemolytic activity of peptides.","volume":"9","author":"Win","year":"2017","journal-title":"Future Med. Chem."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.649339\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:22:21Z","timestamp":1613740941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.649339\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":58,"alternative-id":["10.3389\/fmicb.2021.649339"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.649339","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"article-number":"649339"}}